Latest Blogs

Feb 14, 2018
Patient advocate Ms. Carole Seigel discusses ASCO's new clinical practice guideline on managing immune-related adverse events for patients treated with checkpoint inhibitors.  
Feb 13, 2018
A recent event brought home the significance of how devastating news is received and how we react to a potentially life-changing message.
Feb 05, 2018
Almost every day a patient (and often many more than one) asks Dr. Evan Hall, “How will my cancer diagnosis affect my life?” This is a difficult question to answer. 
Feb 01, 2018
"Can we increase the chances to make early diagnoses in patients with cancer? Yes, we can, I can, but how?" asks Dr. Jose Angel Sanchez.
Subscribe to this column

Daniel F. Hayes, MD, FACP, FASCO, BA

Daniel F. Hayes, MD, FACP, FASCO, is the 2016-2017 ASCO President. Dr. Hayes, a breast cancer specialist, is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center.

An ASCO member since 1986, Dr. Hayes has served the Society in numerous volunteer capacities. He is involved in several ASCO Expert Panels related to breast cancer. He served on the ASCO Board of Directors from 2011-2014, on the Conquer Cancer Foundation Grants Selection Committee, as Chair of the Scientific Program Committee, and on the Journal of Clinical Oncology Editorial Board. In 2007, he was presented with ASCO’s Gianni Bonadonna Breast Cancer Award and Lecture; in 2013, he was elected as a Fellow of ASCO (FASCO). Follow Dr. Hayes on Twitter @hoosierdfh.

Oct 25, 2016
“When are we going to cure cancer?” If I had a dime for every time I’ve been asked that...The trite answer is that we already cure many cancers, just not enough of them! But the real question should be, “Why don’t we cure all cancers?”
Oct 18, 2016
Vice President Joe Biden and the government-wide Cancer Moonshot Task Force have presented today a sweeping vision that, if realized, could change the face of cancer prevention, screening, treatment, and survivorship as we know it.
Aug 24, 2016
Support for federal research funding for cancer is not about politics. It's about people. There is no one in our society—liberal, conservative, libertarian, or just don’t care—who isn’t touched in some way by cancer.
Jul 11, 2016
Believe it or not, the Medicare Access and CHIP Reauthorization Act of 2015 was passed more than 1 year ago, and program changes begin in less than six months, on Janurary 1, 2017.
Jun 13, 2016
Last week I introduced the theme I’ve selected for my term as ASCO President, Together, we’ll be making a difference for our patients and in our profession with the help of some game-changing initiatives from ASCO, of which I will describe just a few.
May 24, 2016
Having completed my year as President-Elect, I have been struck by the many facets in which ASCO does indeed endeavor to conquer cancer—which leads to my Presidential theme, ASCO: Making a Difference in Cancer Care with You.

Pages